Abstract 90: Optimizing Triage Assessments for Large and Medium Vessel Occlusions

Parin P Nanavati,Karen Albright,Claribel Wee,Jane A Anderson,Michael J Lyerly
DOI: https://doi.org/10.1161/str.55.suppl_1.90
IF: 10.17
2024-02-01
Stroke
Abstract:Introduction: Stroke symptom assessment tools are used in various settings, including telestroke triage, to identify patients who may be candidates for endovascular therapy (EVT). EVT is now being offered to more patients including those with medium vessel occlusions (MeVOs). We hypothesize that triage screening tools have differing rates of detection for large vessel occlusions (LVOs) versus medium vessel occlusions (MeVOs). Methods: Using our 2021 stroke registry, we created a retrospective cohort of ischemic stroke patients with LVO, MeVO or no occlusion. Patients were treated with the standard of care (e.g., thrombolytics, EVT). Clinical and radiographic data were abstracted for each case. Patients were evaluated for hemiparesis (HP) and vision, aphasia, or neglect (VAN) using the documented presenting exam. ROC analysis was conducted to evaluate the ability of the HP + VAN screening tool to detect LVOs and MeVOs. Results: The cohort consisted of 299 patients (median age 66 years, 48% female, 36% Black, median NIHSS score 9). Among the 175 patients with recorded HP + one of the VAN signs, 81% (n=141) had an occlusion (LVO or MeVO). HP+VAN criteria was not met by 11% of LVOs and 33% of MeVOs. HP + VAN tool performed best for the combined endpoint of LVO or MeVO (sensitivity 0.83, specificity 0.74, AUC 0.786, Figure). Variations of this tool did not significantly improve performance (additional models with AUCs will be presented) with the exception of changing the score to from HP+VAN to “HP or VAN” (sensitivity 1.00, specificity 0.25). Conclusions: In our sample from a tertiary care center, HP+VAN is a reasonable tool for the detection of LVOs or MeVOs. The only variation that improved sensitivity was screening for hemiparesis or VAN. While this prevented us from missing any LVOs or MeVOs, this approach comes at a heavy cost of reduced specificity.
peripheral vascular disease,clinical neurology
What problem does this paper attempt to address?